Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization-Reference-Cited by-同舟云学术

Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization

Published:2015-12-28 Issue:13 Volume:56 Page:8228
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Nourinia Ramin¹,Rezaei Kanavi Mozhgan¹,Kaharkaboudi Amir¹,Taghavi Seyed Iman²,Aldavood Seyed Javid²,Darjatmoko Soesiawati R.³,Wang Shoujian³,Gurel Zafer³,Lavine Jeremy A.³,Safi Sare¹,Ahmadieh Hamid⁴,Daftarian Narsis¹,Sheibani Nader⁵

Affiliation:

1. Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2. Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

3. Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States

4. Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

5. Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States 5McPherson Eye Research Institute, University Wisconsin School of Medicine and Public Health, Madison, Wiscons

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly(2-isopropenyl-2-oxazoline) Hydrogels with Biodegradable Junction Points for Drug-Delivery Applications;Chemistry of Materials;2024-07-29

2. Polymeric Propranolol Nanoparticles for Intraocular Delivery: Formulation, Characterization, and Vitreous Pharmacokinetics;Journal of Ophthalmic and Vision Research;2024-03-10

3. Editorial – Polymeric Nanoparticles for Retinal Drug Delivery;Journal of Ophthalmic and Vision Research;2024-03-10

4. Intravitreal bevacizumab plus propranolol for neovascular age-related macular degeneration (the BEVALOL study): a phase I clinical trial;International Journal of Retina and Vitreous;2023-04-13

5. Ocular safety of intravitreal ethylene diamine tetra acetic acid (EDTA): An experimental feasibility study;Toxicology Reports;2023